← FDA Drug Approvals (Drugs@FDA)
ANGIOVIST 292
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAYER HLTHCARE · Approved 1982-09-23
Drug application
- FDA Application #
ANDA087724- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ANGIOVIST 292
- Generic name
- Diatrizoate Meglumine
- Active ingredients
- DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- BAYER HLTHCARE
- First approval
- 1982-09-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown